IRS1 and breast cancer: In any case, it is interesting to note that, with few exceptions (such as the effect on skeletal muscle Irs1 expression), on an HFD, the BC+MET cotreatment elicited “all the good” of the individual BC and MET treatments, compensated “the bad” and generated additional favorable effects.